HFSA Cardio Town Hall: Expert Perspectives on Contemporary ATTR-CM Clinical Research

Join this 30-minute Cardio Town Hall, moderated and led by Dr. Mazen Hanna and Dr. Mathew Maurer for an expert discussion on contemporary ATTR-CM clinical research and its relevance to clinical practice, and the opportunity to have Q&A live with these experts.

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease associated with significant morbidity and mortality. As the understanding of ATTR-CM continues to evolve, clinical research plays an important role in advancing knowledge of disease characteristics, patient populations, study design, and emerging approaches to care. Join HFSA’s Cardio Town Hall for an expert discussion on contemporary ATTR-CM clinical research and its relevance to clinical practice.